Expands and coordinates federal attention to uterine fibroids by funding and directing research, improving data collection on Medicaid and CHIP services, and supporting public education and evidence-based clinical outreach. It authorizes $30 million per year for research (FY2026–2030), requires a federal report on Medicaid/CHIP spending for fibroid services within two years, and directs HHS to develop public information and clinician outreach focused on non-hysterectomy treatment options and disparities affecting racial and ethnic minority individuals.